We are live on
!
Find out more
Eli Lilly
1,227 hedge funds and large institutions have $72.7B invested in Eli Lilly in 2017 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 406 increasing their positions, 485 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 24 → 21 (-3)
16% less repeat investments, than reductions
Existing positions increased: 406 | Existing positions reduced: 485
25% less call options, than puts
Call options by funds: $370M | Put options by funds: $493M
Holders
1,227
Holding in Top 10
21
Calls
$370M
Puts
$493M
Top Buyers
| 1 | +$1.15B | |
| 2 | +$263M | |
| 3 | +$234M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$124M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$123M |
Top Sellers
| 1 | -$190M | |
| 2 | -$135M | |
| 3 | -$118M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$103M |
| 5 |
D.E. Shaw & Co
New York
|
-$81.2M |